News

Webinar: Development of Image-Based In Vitro/In Vivo Platform for Targeting CAFs

Explore groundbreaking methodologies in tumour microenvironment (TME) research with our upcoming webinar, designed for scientists and researchers eager to deepen their understanding of cancer-associated fibroblasts (CAFs) and their role in tumour progression. internalseo

In vivo/in vitro platform

Details about the webinar

When?

Wednesday, February 12, 2025 | 9 AM PST / 12 PM EST

What You Will Learn:

Innovative Co-culture Systems: Learn how fluorescent protein-labelled cell lines (e.g., iRFP720, pKatushka) are used to create in vitro co-culture systems that replicate TME’s extracellular and cellular elements.

Translational Insights: Discover how in vitro experiments align with in vivo data, highlighting CAF-mediated tumour cell protection and the reshaping of cancer cell clusters to mimic human tumour tissue.

Key Findings: Gain insights into immune cell cytotoxicity kinetics and tumour resistance trends observed consistently across in vitro and in vivo studies.

Who Can Attend?
This webinar is ideal for cancer researchers, immuno-oncology specialists, and translational scientists looking to stay ahead in the field of cancer biology.

Speaker

Pengyu Huang, Ph.D., Head of In Vivo Pharmacology, Simcere Zaiming & Simnova Biotherapeutics.

Don’t miss this opportunity to gain valuable insights into cutting-edge cancer research: REGISTER HERE.

Can’t attend live? Click here to register and receive a link to the recorded webcast.

You can learn more about our partner Spectral Instruments Imaging here.

Related posts

Preclinical Research with Spectral Instruments Imaging

Preclinical Research with Spectral Instruments Imaging Solutions

The Lago X, Ami HTX, and Kino imaging systems set preclinical optical imaging standards, combining exceptional sensitivity, user-friendly,...
Droplet Microfluidics Technology

Revolutionary droplet microfluidics technology sets the new standard for research

Atrandi's technologies provide innovative high-throughput sample preparation and analysis capabilities in sequencing, AI and personalized medicine....

Be the First to Know About Our News!

Contact us

CONTACT US

CONTACT US

0